Pharma-Bio Serv (PBSV) Profit After Tax Growth (3y) (2013 - 2026)
Pharma-Bio Serv (PBSV) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 25.65% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 105.50% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 156.91% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 35.73% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | -14.58% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -16.63% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 40.22% |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | -16.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -16.81% |
| Jan 31, 2026 | -30.49% |
| Oct 31, 2025 | -26.00% |
| Jul 31, 2025 | -45.65% |
| Apr 30, 2025 | -26.49% |
| Jan 31, 2025 | -69.65% |
| Oct 31, 2024 | 53.38% |
| Jul 31, 2024 | -29.42% |
| Apr 30, 2024 | -48.94% |
| Jan 31, 2024 | -44.39% |
| Oct 31, 2023 | -33.11% |
| Jul 31, 2023 | -8.73% |
| Apr 30, 2023 | -16.20% |
| Jan 31, 2023 | -6.81% |
| Oct 31, 2022 | -10.57% |
| Jul 31, 2022 | -12.58% |
| Apr 30, 2022 | -30.25% |
| Jan 31, 2022 | -13.46% |
| Oct 31, 2021 | -129.51% |
| Jul 31, 2021 | 75.11% |